Journal article
Xenografted human microglia display diverse transcriptomic states in response to Alzheimer’s disease-related amyloid-β pathology
- Abstract:
- This thesis explores virus-induced neuropathology using human stem cell-derived organotypic models that mimic the molecular and cellular complexity of the central nervous system (CNS). Chapter 1 introduces the challenges in studying viral neurological disease, emphasizing the limitations of traditional models and the potential of neural organoids as human-relevant systems. Chapter 2 highlights the importance of unified terminology and context-dependent host–virus interactions in understanding neuropathology.Part I focuses on modeling neuropathology caused by human Parechoviruses (HPeV) and Human Immunodeficiency Virus (HIV). Neural organoids were used to show that the neurovirulent HPeV-3, but not HPeV-1, induces strong immune and metabolic disturbances rather than differences in viral replication or tropism. Reanalysis revealed disrupted immunometabolism and glutamate excitotoxicity, implicating host metabolic imbalance in disease severity. Using microglia-containing organoids, HIV infection studies showed that microglia facilitate viral persistence, elevate HIV gene expression, and promote inflammatory amino acid metabolism, highlighting their role as reservoirs contributing to HIV-associated neurocognitive disorders.Part II applies organoid platforms for antiviral testing. Halofuginone Hydrobromide showed broad-spectrum antiviral potential in organoid systems but limited efficacy at clinically relevant concentrations, demonstrating the translational value of organoids for assessing both efficacy and toxicity.Together, these studies establish human iPSC-derived neural organoids as powerful models for studying viral infection, immune–metabolic crosstalk, and therapeutic interventions. Their multicellular architecture and human relevance position them as essential tools for mechanistic discovery, antiviral screening, and the advancement of precision medicine in neurovirology
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 18.7MB, Terms of use)
-
- Publisher copy:
- 10.1038/s41593-024-01600-y
- Publication website:
- https://pure.uva.nl/ws/files/272362641/Chapter_1.pdf
Authors
+ Universiteit Antwerpen
More from this funder
- Funder identifier:
- 10.13039/501100007660
- Grant:
- FFB210307
+ Alzheimer’s Association
More from this funder
- Funder identifier:
- 10.13039/100000957
- Grant:
- AARF-20-684397
+ Fonds Wetenschappelijk Onderzoek
More from this funder
- Funder identifier:
- 10.13039/501100003130
- Grant:
- G0C9219N
+ EC | Horizon 2020 Framework Programme
More from this funder
- Funder identifier:
- 10.13039/100010661
- Grant:
- CELLPHASE_AD
- Publisher:
- Nature Research
- Journal:
- Nature Neuroscience More from this journal
- Volume:
- 27
- Issue:
- 5
- Pages:
- 886-900
- Publication date:
- 2024-03-27
- DOI:
- EISSN:
-
1546-1726
- ISSN:
-
1097-6256
- Language:
-
English
- Keywords:
- Pubs id:
-
1989809
- Local pid:
-
pubs:1989809
- Source identifiers:
-
W4393225316
- Deposit date:
-
2026-06-10
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2024
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record